Skip to main content

Table 2 Means (± s.d) of the TGF-β 1 and PDGF-BB concentrations (pg/mg of total protein (TP)) in every blood component obtained with every anticoagulant

From: Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel

Variable Blood component
  Plasma P-PRP lysate P-PRG PPP lysate PPG
SC      
PDGF-BB (pg/mg of TP) 0.9 (0.6)a,b 25.2 (14.4)c 19.0 (29.4)d 8.3 (5.4)d 4.5 (5.5)
TGF-β1(pg/mg of TP)* 26.8 (10.4)a,e 90.7 (30.7)c,e 54.5 (33.1) 45.2 (10.3)d 29.2 (17.1)
ACD-A      
PDGF-BB (pg/mg of PT) 1.0 (0.6)a,b 28.2 (20.1)c 11.3 (30.6) 8.2 (5.0) 5.8 (8.0)
TGF-β1(pg/mg of TP)* 30.0 (8.7)a 101.5 (31.2)c,e 56.4 (39.1) 47.8 (12.2) 33.3 (17.9)
ACD-B      
PDGF-BB (pg/mg of TP) 1.1 (0.9)a 18.4 (13.4)b 6.6 (17.3) 7.2 (4.1) 4.8 (6.5)
TGF-β1(pg/mg of TP)* 27.5 (10.0)c 87.8 (23.0)d 50.8 (31.2) 44.6 (12.9) 31.3 (12.7)
  1. *Data are presented as medians (IR). P-PRG: pure platelet-rich gel; PPG: platelet-poor gel. Lowercase letters represent independent significant differences for every blood component obtained with a specific anticoagulant. SC: blood component different with a: P-PRP and PPP lysates (P <0.001); b: P-PRG and PPG (P <0.05); c: PPP lysate and PPG (P <0.001); d: PPG (P <0.05); and e: P-PRG (P <0.05). ACD-A: blood component different with a: P-PRP and PPP lysates (P <0.001); b: P-PRG and PPG (P <0.05); c: PPP lysate and PPG (P <0.001); d: PPG; and e: P-PRG (P <0.05). ACD-B: blood component different a: all blood components (P <0.05); b: PPP lysate and PPP (P <0.05); c: P-PRP lysate (P <0.05); d: PPP lysate and PPG (P <0.05).